CClinicalTrials.gg
CompletedNCT02859051Updated Apr 27, 2021

MEDi Robot for Pain Management at Induction

An interventional study of Humanoid Robot MEDi in Cognitive Therapy, sponsored by University of Calgary. Completed at 1 site in Canada. Open to participants aged 4 Years to 12 Years. Per ClinicalTrials.gov, last updated 2021-04-27.

Sponsored by University of Calgary · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
137
Allocation
Non-randomized
Ages
4 Years to 12 Years
Sex
All
01

Study summary

The purpose of this study is to determine if a preparation teaching intervention before IV insertion, taught by MEDi to children and their parents, will lead to lower levels of expected and experienced pain and fear and less distressing pain memories, as compared to children who receive standard care. In addition, it will be examined whether this preparation intervention will lead to greater parental self-efficacy, less anxiety, and less distressing pain memories as compared to controls.

Read the detailed description

The primary aim is to determine the impact of using a humanoid robot in comparison to standard care. This proposal describes the first study in the world to test such novel technology for preparation teaching intervention before IV insertion. This work builds on previous research conducted by the research team and represents a logical next step for this collaborative group. This project team includes established and emerging leaders in pain management research. This will ensure successful implementation and completion of the project. These methods of teaching preparation have the potential for widespread application to other medical procedures and clinical settings (eg. oncology dentistry) and lead to improved health outcomes for children by easing their suffering and improving the quality of their healthcare encounters.

1.2 Research Questions

Research Question 1.) Does preparation administered by a humanoid robot (MEDi) reduce expectancies and experience of pain and fear of IV insertion in children?

Hypothesis 1.) Children who receive preparation by MEDi will report expecting and experiencing lower levels of fear and pain at IV insertion as compared to youth receiving standard care.

Research Question 2.) Does preparation administered by MEDi lead to higher self-efficacy and lower anxiety in parents of children undergoing IV insertion?

Hypothesis 2.) Parents of children who receive preparation by MEDi will report higher levels of self-efficacy and lower anxiety at their children's IV insertion as compared to youth receiving standard care.

Research Question 3.) Do children who receive preparation administered by MEDi and their parents have more accurate and positively estimated memories of pain and fear as compared to youth receiving standard care and their parents?

Hypothesis 3.) Children who receive preparation administered by MEDi and their parents will report more accurate and positively estimated memories of pain and fear as compared to youth receiving standard care and their parents.

Research Question 4.) Do children who receive preparation administered by MEDi prior to IV insertion and their parents expect to experience less pain, fear, anxiety, and higher self-efficacy in pain coping at future needle procedures as compared to youth receiving standard care and their parents?

Hypothesis 4.) Children who receive preparation administered by MEDi prior to IV insertion and their parents will report expecting to experience lower pain, fear, and anxiety and higher self-efficacy in pain coping at future needle procedures as compared to youth receiving standard care and their parents.

2.1 Study Design \& Setting

This study is a single-centre prospective randomized, controlled, two-armed trial: (1) humanoid robot, MEDi, provides preparation for intravenous placement; and (2) standard care. Patients will be recruited from day surgery at the Alberta Children's Hospital Calgary, AB. This study will follow the high methodological standards for reporting RCTs according to the Consolidated Standards of Reporting Trials guidelines - extension for nonpharmacological treatments and this trial will be registered with clinicaltrials.gov.

2.2. Study Population

Legal guardians and/or patients with the ability to understand the study will be asked to provide written informed consent prior to participation. Day surgery patients, between the ages of 4-12 years old who are presenting for general surgery under general anesthesia, and in the American Society of Anesthesiologists class 1 or 2, will be included.

02

Conditions studied

  • Cognitive Therapy

Keywords

  • Cognitive Behavioral Support provided by Robot
03

In context

Lead sponsor

University of Calgary is the lead sponsor of 686 studies on the registry; 189 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 2 (20%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
4 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • presenting for general surgery under general anesthesia, and in the American Society of Anesthesiologists class 1 or 2

Exclusion criteria

Exclusion Criteria:

  • patient presenting for day surgery
  • patient requires an intravenous placed in day surgery unit
  • patient cognitively unable to self-report pain
  • patient with a hearing or visual impairment or developmental disability that precludes self-reporting ability
  • family or child that is unable to communicate in English
  • previous allergic reaction to propofol or lidocaine
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
137 participants (estimated)

Study arms

  • No intervention
    control

    No intervention

  • Experimental
    robot

    Humanoid robot interacts with child, teaching breathing and coping strategies.

    Device: Humanoid Robot MEDi

Interventions

  • DeviceHumanoid Robot MEDi

    Humanoid robot programmed with cognitive-behavioral interventions such as role modeling, teaching coping strategies, positive reinforcement, parent encouragement

06

What researchers measure

Primary outcomes

  1. child's pain

    Faces Pain Scale-Revised (FPS-R) (Hicks, 2001)

    Time frame: at moment of child's IV start

Secondary outcomes

  1. child's fear

    Children's Fear Scale (McMurtry, Noel, Chambers, \& McGrath, 2011)

    Time frame: at the moment of OR entry

  2. parent self-efficacy

    use 0-10 numerical rating scales to report the degree to which they feel self-efficacy in their ability to help their child manage their pain and fear

    Time frame: 30 mins to 3 hours before induction

  3. parent anxiety

    Parents will be asked to report on their own level of anxiety during the needle procedure using a 0-10 NRS ranging from 0 ('not at all nervous or anxious') to 10 ('most nervous or anxious').

    Time frame: 30 mins to 3 hours before induction

  4. children's memory

    , parents and children will be asked to provide their free recall of each of those periods using open-ended prompts

    Time frame: 2 weeks after child's induction

  5. parents' memory

    , parents and children will be asked to provide their free recall of each of those periods using open-ended prompts

    Time frame: 2 weeks after child's induction

07

Study locations

1 site
  • Alberta Children's Hospital
    Calgary, Alberta T3B 6A8, Canada
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02859051
Lead sponsor
University of Calgary
Collaborators
Alberta Health services
Responsible party
Tanya Beran (Professor, University of Calgary) — Principal investigator
First posted
Aug 8, 2016
Start date
Jul 8, 2016
Primary completion
May 25, 2018
Completion
May 25, 2018
Last update
Apr 27, 2021

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion